Belal Hijji | Pharmacology | Best Researcher Award

Belal Hijji | Pharmacology | Best Researcher Award

Assist. Prof. Dr. Belal Hijji, Prince Sattam Bin Abdulaziz University, Saudi Arabia

Assistant Professor Dr. Belal Hijji is a distinguished nursing academic with a Ph.D. in Adult Health Nursing from the University of Ulster, UK. He has served in academic and clinical roles across Jordan, Saudi Arabia, Libya, and the UAE. With a strong focus on blood transfusion safety, he has authored books and peer-reviewed articles, including in Journal of Clinical Nursing and Nursing Reports. Dr. Hijji is passionate about nursing education, patient safety, and ethical research, and is fluent in both Arabic and English. He currently teaches at Prince Sattam bin Abdulaziz University, KSA.

Publication Profile

Google Scholar

Education

Assist. Prof. Dr. Belal Hijji is a distinguished academic with a robust background in nursing education and research. He earned his Bachelor of Nursing from Yarmouk University, Jordan (1983–1987), followed by an MSc in Nursing Studies from the University of Manchester, UK (1999–2001), where he conducted a thesis on students’ perceptions of nursing as a career. He later achieved a Ph.D. in Adult Health Nursing from the University of Ulster, UK (2003–2007), focusing on blood transfusion practices among nurses in Abu Dhabi. 🧠 In 2017, he also earned certification in human research participant protection from the NIH.

Awards

Assist. Prof. Dr. Belal Hijji has enriched his professional journey through a variety of specialized training courses. His early learning included managing hypertension and heart failure (1987) and infection control in London (1996). 🏥 He attended the 2nd GCC Seminar on Gerontology in Abu Dhabi (1997) and gained critical appraisal skills in Oxford (2000). He also participated in conferences on healthcare ethics (2002), medical statistics (2004), and qualitative research at the University of Ulster. 📊 His continuous learning extended through webinars on learning psychology (2022) and contributing to the UN Sustainable Development Goals (2022). 🌍 Lifelong learning remains his driving force.

Experience

Assist. Prof. Dr. Belal Hijji has held numerous academic and clinical roles across the Arab world. Since September 2019, he has served as Assistant Professor of Nursing at Prince Sattam bin Abdulaziz University, KSA. 🇸🇦 Previously, he taught at Al Ghad International Colleges (2015–2019), Benghazi University, Libya (2012–2015), and the University of Ha’il (2011–2012). 🏫 Earlier roles include Assistant Professor at Philadelphia University, Jordan (2008–2010). From 1987 to 2005, he worked in diverse clinical and administrative positions within regional ministries of health. 🏥 His leadership also included overseeing scientific affairs and curriculum development. 📘 His dedication to nursing education spans decades.

Research Focus

Assistant Professor Dr. Belal Hijji’s research primarily centers on blood transfusion knowledge and safety among nurses, with a strong emphasis on nursing education, clinical practice, and assessment tools. His studies span diverse healthcare settings in Jordan and the UAE, investigating nurses’ competencies, transfusion practices, and educational gaps. Additionally, he explores the effectiveness of assessment tools like multiple-choice questions and mathematical skills in dosage calculation, highlighting critical aspects of nursing proficiency. Through observational studies and survey research, Dr. Hijji contributes valuable insights into improving patient safety and enhancing nursing curricula.

Publication Top Notes

Knowledge of blood transfusion among nurses

Measuring knowledge of blood transfusion: A survey of Jordanian nurses

Nurses’ practice of blood transfusion in the United Arab Emirates: an observational study

Flaws of multiple choice questions in teacher-constructed nursing examinations: A pilot descriptive study

Trained nurses’ knowledge and practice of oral care on three wards in acute care hospital in Abu Dhabi, UAE

Item Analysis of the Modified Version of the Routine Blood Transfusion Knowledge Questionnaire

Knowledge and practice of blood transfusion: A survey of nurses in Abu Dhabi, United Arab Emirates

An Indispensable Requirement for Medical Dosage Calculation: Basic Mathematical Skills of Baccalaureate Nursing Students

The Science of Multiple-Choice Questions (MCQs)

Azhagu Madhavan | Pharmaceutical Analysis | Excellence in Research

Azhagu Madhavan | Pharmaceutical Analysis | Excellence in Research

Dr. S. Azhagu Madhavan, Saveetha Medical College and Hospital, Saveetha Institute of Medical and Technical Sciences, Tamil Nadu, India

Dr. S. Azhagu Madhavan, M.Sc., Ph.D., is an Assistant Professor at Saveetha Medical College and Hospital, Chennai, India. His academic background spans Zoology and Biotechnology, with a focus on pharmacology, pharmacognosy, phytochemistry, and nanotechnology. His Ph.D. research explored the pharmacological effects of Costus Spicatus in diabetic rats. He has several patents, including innovations in biosensors and biodegradable products. Dr. Madhavan has contributed to high-impact journals in neuroscience, immunology, and nanobiotechnology. He is passionate about advancing natural products and nanobiotechnology for healthcare and environmental applications.

Publication Profile

Google Scholar

Education

Dr. S. Azhagu Madhavan is an accomplished academic with a strong foundation in Zoology and Biotechnology. He earned his Ph.D. in Zoology from A Veeriya Vandayar Memorial Sri Pushpam College (an autonomous institution affiliated with Bharathidasan University) in Poondi, Thanjavur, Tamil Nadu, India, from 2016 to 2020. His academic journey began with a Master’s in Zoology (2014-2016) followed by a Bachelor’s in Zoology and Biotechnology (2011-2014), both from the same esteemed institution. Dr. Madhavan’s educational background reflects his deep passion for biological sciences and commitment to advancing knowledge in his field.

Experience

Dr. S. Azhagu Madhavan has accumulated valuable experience in the academic and research fields. He is currently serving as an Assistant Professor at Saveetha Medical College and Hospital, Saveetha Institute of Medical and Technical Sciences (SIMATS), Chennai, since 2022. Previously, he worked as a Research Associate at Global Scientific Research Services, Ariyalur (2020-2021), and as a Research Assistant at Harman Institute of Science Education and Research, Thanjavur (2016-2017). With a total of 4 years and 8 months of experience, Dr. Madhavan has significantly contributed to the field of biological sciences.

Awards

Dr. S. Azhagu Madhavan has made notable contributions to the scientific community through his oral presentations. One of his significant presentations, titled “Earthworm Cut of Bacteria and Fungus Analysis Eisenia fetida,” was delivered at the National Conference on Trends in Healthcare and Biotechnology in 2016. In addition to this, he was invited as a speaker for the event Opportunities & Challenges (THBOC-2016), organized by the P.G & Department of Zoology and Biotechnology, A.V.V.M Sri Pushpam College. His ongoing efforts continue to impact the field of healthcare and biotechnology.

Research Focus

Dr. S. Azhagu Madhavan’s research primarily focuses on phytochemistry, nanotechnology, and medicinal plants. His studies include phytochemical screening, GC-MS analysis, and green synthesis of nanoparticles from various plant extracts such as Silybum marianum, Murraya koenigii, and Avicennia marina. He explores the bioactive compounds in these plants for their antioxidant, anticancer, antibacterial, and antidiabetic properties. His work on silver nanoparticles also highlights their potential applications in biomedical sciences. His contributions significantly impact areas like pharmacology and nanomedicine.

Publication Top Notes

Phytochemical screening and GC-MS analysis of bioactive compounds present in ethanolic leaves extract of Silybum marianum (L).

Potential of banana based cellulose materials for advanced applications: A review on properties and technical challenges

Green synthesis and characterization of silver nanoparticles with different solvent extracts of Sesbania grandiflora (L.) Poiret and assessment of their antibacterial …

Phytochemical screening and GC–MS analysis of bioactive compounds present in ethanolic leaf extract Murraya koenigii

Polyphenol-compounds From Green Synthesis of Antimicrobial property of Silver Nanoparticles using Eichhornia crassipes: Characterization and Applications

Phytochemical screening and comparative gc–ms analysis of bioactive compounds present in methanolic leaf and latex extract Calotropis gigantea (L)

Extraction, biosynthesis, and characterization of silver nanoparticles for its enhanced applications of antibacterial activity using the Silybum marianum Linn. plant

Identification and characterization of silver nanoparticles from Erythrina indica and its antioxidant and Uropathogenic antimicrobial properties

Anticancer activity of Pedalium murex linn methanolic leaves extract against A549 human lung cancer cell line

Bekri Melka Abdo | Drug Discovery and Development | Top Pharmaceutical Scientist Award

Bekri Melka Abdo | Drug Discovery and Development | Top Pharmaceutical Scientist Award

Mr. Bekri Melka Abdo, Ethiopian Institute of Agricultural Research, Ethiopia

Bekri Melka Abdo is a dedicated organic chemist specializing in natural product chemistry 🌿. With expertise in plant sample collection, extraction, compound isolation, and structure elucidation, he focuses on bioactive compounds from Ethiopia’s medicinal and aromatic plants. His research contributes to developing natural product-based treatments for leishmaniasis 🦠. He has two published journal articles, an h-index of 7, a Google patent, and an ISBN-registered book 📖. Actively engaged in research and consultancy, Bekri is committed to innovative drug discovery and advancing natural product chemistry for global health.

Publication Profile

orcid

Education

Bekri Melka Abdo is a dedicated professional in organic chemistry 🧪, specializing in natural product chemistry 🌿. His expertise encompasses plant sample collection and preparation, extraction, compound isolation, and structure elucidation. He is skilled in qualitative and quantitative analysis, as well as biological activity determination of natural products extracted from various aromatic and medicinally significant 🌱 exotic and endemic plant species of Ethiopia. With a strong foundation in the field, he contributes to the discovery and characterization of bioactive compounds, supporting advancements in medicine, pharmaceuticals, and biotechnology 🔬. His research plays a vital role in exploring Ethiopia’s rich botanical resources.

Experience 

Bekri Melka Abdo is a passionate researcher in natural product chemistry 🌿, with a strong track record of research and innovation 🔬. He has successfully completed two research projects and maintains an h-index of 7 📊. His contributions extend to industry consultancy and collaborative projects, showcasing his impact in the field. He has authored a book with an ISBN 📖 and has a Google patent pending. His work is recognized in SCI and Scopus-indexed journals 🏅, with two publications. Actively engaged in editorial roles and professional memberships, he continues to drive scientific advancements in bioactive compound discovery.

Award

Bekri Melka Abdo, with his early career achievements and promising research in natural product chemistry 🌿, is an ideal candidate for the Young Scientist Award 🏆. His dedication to bioactive compound discovery, coupled with his impactful contributions to scientific research and innovation 🔬, highlights his potential for future breakthroughs. With a strong foundation in natural product extraction, analysis, and biological activity determination, he is paving the way for new discoveries in medicine and biotechnology 💊. This award category recognizes emerging researchers like Mr. Abdo, whose work demonstrates both excellence and the promise of transformative scientific advancements.

Research Focus

Mr. Bekri Melka Abdo specializes in phytochemistry and antiparasitic drug discovery, focusing on the bioassay-guided isolation of natural compounds for therapeutic applications. His research on dehydrocostus lactone from Echinops kebericho highlights its potential as a leishmanicidal drug 🦟⚕️. His work integrates natural product chemistry, pharmacognosy, and infectious disease research, contributing to novel drug development against leishmaniasis. By combining traditional medicinal plants with modern bioassays, he advances the search for effective, plant-derived antiparasitic treatments 🌱🔬. His research holds promise for addressing neglected tropical diseases through sustainable and nature-inspired therapies.

Xia Xiao | Pharmacodynamics | Best Researcher Award

Xia Xiao | Pharmacodynamics | Best Researcher Award

Assoc. Prof. Dr. Xia Xiao, Yangzhou University, China

Assoc. Prof. Dr. Xia Xiao is a distinguished researcher in veterinary microbiology at Yangzhou University. He earned his Ph.D. in Veterinary Science from South China Agricultural University (2015) 🎓, specializing in bacteriophage-mediated antibiotic resistance. His research focuses on antimicrobial pharmacokinetics, novel antimicrobial agents, and bacterial resistance mechanisms 🦠💊. A former visiting scholar at UCLA (2018-2019), Dr. Xiao has published extensively in high-impact journals 📚. His work contributes to the rational use of antibiotics and combating multidrug resistance, advancing veterinary and human medicine alike. 🏆🔍

Publication Profile

Scopus

Education

Assoc. Prof. Dr. Xia Xiao is a leading veterinary microbiologist at Yangzhou University. He earned his Ph.D. in Veterinary Science from South China Agricultural University (2015) 🎓, specializing in bacteriophage-mediated antibiotic resistance. As a former visiting scholar at UCLA (2018-2019) 🌍, his research focuses on antimicrobial pharmacokinetics, novel antimicrobial agents, and bacterial resistance mechanisms 🦠💊. Since 2020, he has been an Associate Professor, contributing to advancements in antibiotic utilization and resistance control. His work plays a crucial role in improving both veterinary and human medicine. 📚

Experience

Assoc. Prof. Dr. Xia Xiao is a veterinary microbiologist at Yangzhou University, specializing in antimicrobial resistance 🦠💊. He earned his Ph.D. from South China Agricultural University (2015) 🎓, focusing on bacteriophage-mediated antibiotic resistance. As a Visiting Scholar at UCLA (2018-2019) 🌍, he expanded his research through international collaborations, enhancing his contributions to the global scientific community 🔬🤝. His work explores antibiotic pharmacokinetics, novel antimicrobial agents, and bacterial resistance strategies. Since 2020, he has been an Associate Professor, making impactful strides in veterinary and human medicine. 📚🏆

Focus Areas

Assoc. Prof. Dr. Xia Xiao is a veterinary microbiologist at Yangzhou University, specializing in antimicrobial resistance and antibiotic optimization 💊📊. He earned his Ph.D. from South China Agricultural University (2015) 🎓 and later expanded his research through international collaboration as a Visiting Scholar at UCLA (2018-2019) 🌍. His work focuses on pharmacokinetics-based antibiotic use, novel antimicrobial development, and strategies to combat bacterial resistance 🏥⚕️. His groundbreaking research on bacteriophage-mediated resistance transmission addresses global health challenges, making significant contributions to veterinary and medical microbiology. 📚🏆

Research Focus

Assoc. Prof. Dr. Xia Xiao’s research primarily focuses on antimicrobial resistance (AMR) 🦠💊, pharmacokinetics/pharmacodynamics (PK/PD) modeling 📊🧪, and bacterial resistance mechanisms 🔬🧫. Her work explores the role of resistance genes, such as mcr-1, blaNDM-5, and tet(X4), in multidrug-resistant pathogens, including Klebsiella pneumoniae and Escherichia coli. She investigates novel strategies to combat AMR, including using natural compounds 🌿, repurposed drugs 💡, and PK/PD-based optimization 📉📈. Her research has significant implications for developing effective treatments against drug-resistant infections in both humans and animals 🏥🐾.

Publication Top Notes

DNA Polymerase IV dinB Favors the Adaptive Fitness of mcr-carrying Bacteria Through a Negative Feedback Regulatory Mechanism

Acetylshikonin Derived From Arnebia euchroma (Royle) Johnst Kills Multidrug-Resistant Gram-Positive Pathogens In Vitro and In Vivo

Acetylshikonin reduces the spread of antibiotic resistance via plasmid conjugation

The Food Additive Benzaldehyde Confers a Broad Antibiotic Tolerance by Modulating Bacterial Metabolism and Inhibiting the Formation of Bacterial Flagella

Gramine sensitizes Klebsiella pneumoniae to tigecycline killing

Characterization of a cfr-bearing integrative and conjugative element in Proteus cibarius coharbouring tet(X6) on the chromosome

Yuzhu Cai | Pharmacology | Best Researcher Award

Yuzhu Cai | Pharmacology | Best Researcher Award

Dr. Yuzhu Cai, Beihang University, China

Dr. Yuzhu Cai is a dedicated researcher in software engineering, currently pursuing a Ph.D. at Beihang University, China. He earned his Bachelor’s degree in Information Security with a Mathematics minor from Nankai University. An award-winning innovator, he has secured top honors in national competitions, including cryptography, algorithm design, and mathematical modeling. His research spans AI ethics, cybersecurity, and password security, with notable publications in Cell Patterns and ICLR 2025. Co-founder of Han Hai Xing Tu Technology, he pioneers AI-driven educational platforms. His contributions in cryptography and AI showcase his passion for innovation and security. ✨📊

Publication Profile

Education

Dr. Yuzhu Cai 🎓 is a dedicated scholar in the field of software engineering. He is currently pursuing his Ph.D. in Software Engineering at Beihang University, Tianjin, China (Sept 2024 – Present) 🖥️. Prior to this, he earned his Bachelor of Science in Information Security from Nankai University (Sept 2020 – Jul 2024) 🔐. Alongside his major, he also pursued a Minor in Mathematics (Sept 2021 – June 2023) ➗, further strengthening his analytical skills. With a strong academic foundation and a passion for innovation, Dr. Cai continues to advance in the field of technology and cybersecurity.

Awards

Dr. Yuzhu Cai 🎖️ has received numerous prestigious awards for his excellence in information security, cryptography, and mathematics. He secured First Prize in the National Information Works Competition 🏆, along with the Most Innovative and Entrepreneurial Value Award. He also won First Prize in the 7th National Cryptography Technology Competition 🔐 and the National College Students’ Mathematical Modeling Competition (Tianjin Area) 📊. His achievements include a Bronze Medal in the National Algorithm Design and Programming Challenge 💻 and First Prize in the Tianjin Electronic Design Competition. Additionally, he earned multiple scholarships 🏅, including Nankai University’s Public Ability and Innovation Scholarships. 🚀

Scientific Contributions

Dr. Yuzhu Cai 🧑‍🔬 has made remarkable contributions to the field of artificial intelligence and cybersecurity. He has co-authored influential publications in top-tier journals like Cell Patterns 📄 and presented groundbreaking research at ICLR 2025 🤖, focusing on AI ethics and multi-agent collaboration networks. His ongoing studies delve into password security 🔐, large language models (LLMs) 🧠, and AI-driven educational platforms 🎓, showcasing his dedication to cutting-edge innovation. With a strong research portfolio and a passion for technological advancements, Dr. Cai continues to shape the future of AI and cybersecurity. 🚀

Industry

Beyond academic research, Dr. Yuzhu Cai 🌟 has played a key role in applied technology projects, bridging the gap between innovation and real-world solutions. He contributed to HoneyCloud ☁️🔐, a secure multi-cloud password manager, enhancing cybersecurity practices. Additionally, he was involved in Han Hai Xing Tu 🎓🤖, an AI-driven educational planning platform, revolutionizing personalized learning. His entrepreneurial mindset 💡 and collaborative research efforts strengthen his influence across both academia and industry. With a passion for technological advancement and practical solutions, Dr. Cai continues to drive impactful innovations in AI, security, and education.

Research Focus

Dr. Yuzhu Cai’s research focuses on ensuring the ethical use of AI, particularly in aligning open-source text-to-image models with societal values. In the paper “Ethical-Lens: Curbing Malicious Usages of Open-Source Text-to-Image Models,” Dr. Cai and colleagues introduce Ethical-Lens, a framework designed to prevent the generation of harmful or biased content by these models. This framework operates without altering the internal structures of existing models, instead refining user inputs and adjusting outputs to adhere to ethical standards. By addressing issues like toxicity and bias, Ethical-Lens aims to promote the responsible development and integration of AI tools into society.

Hui Xiao | Drug Discovery and Development | Pharmaceutical Innovation Achievement Award

Hui Xiao | Drug Discovery and Development | Pharmaceutical Innovation Achievement Award

Dr Hui Xiao,regeneron,United States

Dr. Hui Xiao 🧪🔬 is a distinguished scientist specializing in biochemistry, structural biology, and mass spectrometry. With a strong focus on microtubule dynamics, protein interactions, and drug mechanisms, he has made significant contributions to understanding cellular processes. As a co-first author and lead researcher, his work has been published in esteemed journals like J. Mol. Biol., Biochemistry, and J. Biol. Chem.. His expertise spans hydrogen-deuterium exchange, proteomics, and molecular stabilization studies. Dr. Xiao’s research has advanced drug discovery, particularly in cancer therapeutics and protein biochemistry. 📚🔍 His innovative approaches continue to impact biomedical sciences globally. 🌍✨

Publication Profile

Scopus

Education

Dr. Hui Xiao 🎓 holds a Ph.D. in Analytical Chemistry from the University of Massachusetts, Amherst (2005) and a degree in Applied Chemistry from Peking University, China (1992). Currently serving as an Associate Director at Regeneron Pharmaceuticals 🏢, he specializes in protein characterization using mass spectrometry. With over a decade at Regeneron, he has progressed through roles as a Senior Staff Scientist and Staff Scientist. Previously, he held academic positions at Albert Einstein College of Medicine 🧬, advancing from Instructor to Research Associate Professor. His expertise spans analytical chemistry, protein analysis, and therapeutic protein research, making significant contributions to biomedical science. 🔬

Professional Impact

Dr. Hui Xiao 🎓 is a distinguished scientist with over 20 years of experience in academia and the biotechnology industry. Currently, he serves as an Associate Director of Analytical Chemistry at Regeneron Pharmaceuticals 🏢, a leading biotech company. His expertise lies in mass spectrometry applications for protein characterization 🔬, contributing to advancements in therapeutic development. Before joining Regeneron, Dr. Xiao held esteemed faculty positions at Albert Einstein College of Medicine 🧬, progressing from Instructor to Research Associate Professor. His extensive research and leadership have played a crucial role in bridging analytical chemistry with biopharmaceutical innovation, impacting drug discovery and development. 🚀

Scientific Contributions

Dr. Hui Xiao 🎓 is a leading expert in protein-ligand interactions, structural proteomics, and therapeutic protein analysis 🔬. His pioneering work includes the application of hydrogen-deuterium exchange mass spectrometry (HDX-MS) for epitope mapping 🧩 and microtubule stabilization research. With a deep focus on drug characterization and regulatory sciences, his contributions have significantly advanced biopharmaceutical development 💊. His expertise in mass spectrometry-driven protein analysis has helped enhance the understanding of molecular mechanisms, improving therapeutic strategies. Through innovation and research, Dr. Xiao continues to play a vital role in shaping the future of biopharmaceutical science and drug discovery. 🚀

Potential Considerations

Dr. Hui Xiao 🎓 is a renowned expert in analytical and protein chemistry, with groundbreaking work in epitope mapping and protein characterization 🔬. While his contributions significantly impact drug development, the Pharmaceutical Innovation Achievement Award 🏆 may prioritize direct advancements in drug discovery and novel pharmaceutical interventions 💊. His research has important regulatory and therapeutic implications, but highlighting specific drug innovations or regulatory breakthroughs he has led would further strengthen his case. By showcasing his role in pioneering pharmaceutical advancements, Dr. Xiao’s influence in shaping modern biopharmaceutical science can be fully recognized and appreciated. 🚀

Research Focus

Dr. Hui Xiao’s research primarily focuses on analytical chemistry 🧪, particularly in the quantitative analysis of biomolecules 🧬 using advanced mass spectrometry techniques ⚖️. His work involves CRISPR sgRNA modification analysis 🧬🔬 and the development of LC-MS-based assays for biological therapeutics 💊. He specializes in phosphorothioate isomer detection 🔄 and liquid chromatography-multiple reaction monitoring-mass spectrometry (LC-MRM-MS) 📊 for precise biomolecular quantification. His contributions are crucial in drug discovery 🏥, gene editing 🧬, and biopharmaceutical development 💉. His expertise bridges biotechnology 🔬 and analytical methodologies 📈, advancing innovations in therapeutic monitoring and molecular diagnostics 🏥.

Publication Top Notes

Quantitative Analysis of Phosphorothioate Isomers in CRISPR sgRNA at Single-Residue Resolution Using Endonuclease Digestion Coupled with Liquid Chromatography Cyclic Ion Mobility Mass Spectrometry (LC/cIMS)

Generic Enrichment Method for Liquid Chromatography-Multiple Reaction Monitoring-Mass Spectrometry Assay for Quantitative Measurement of Biological Therapeutics in Serum

Ratree Sawangjit | Pharmacovigilance | Best Researcher Award

Ratree Sawangjit | Pharmacovigilance | Best Researcher Award

Assist Prof Dr Ratree Sawangjit, Mahasarakham University, Thailand

Assist. Prof. Dr. Ratree Sawangjit 🌿, a distinguished educator and researcher, has been a faculty member at Mahasarakham University’s Faculty of Pharmacy since 2006. She earned her Ph.D. in Biopharmaceutical Sciences 🧪 from Mahidol University. Her expertise spans clinical trials, herbal medicine, and evidence-based synthesis 📊. As Head of CTEBs Research Unit and IRB/EC, she leads impactful research projects. Dr. Sawangjit has held roles at Monash University 🌏 and contributed to WHO-GCTM initiatives. Recognized as an outstanding researcher 🏆, her work bridges clinical pharmacology, public health, and education, fostering innovative healthcare solutions.

Publication Profile

Google Scholar

Education

Assist. Prof. Dr. Ratree Sawangjit is a distinguished academic in pharmaceutical sciences 🎓💊. She earned her Ph.D. in Biopharmaceutical Sciences (International Program) from Mahidol University, Faculty of Pharmacy, Bangkok, Thailand (2008-2012) 🧪📚. Prior to this, she completed her Master’s in Pharmacy, specializing in Pharmaceutical Sciences (International Program), at Naresuan University, Thailand (2004-2006) 🏫🔬. Her journey in pharmacy began with a Bachelor of Pharmacy degree from Chiang Mai University, Thailand (1999-2004) 🌿📖. With her extensive education and expertise, she contributes significantly to the field of biopharmaceutical sciences through teaching and research 🌟📊.

Experience

Assist. Prof. Dr. Ratree Sawangjit is a dedicated faculty member at the Department of Clinical Pharmacy, Mahasarakham University (2006–present) 📚💊. She earned her Ph.D. in Biopharmaceutical Sciences from Mahidol University 🎓 (2012) and holds advanced degrees in Pharmacy from Naresuan and Chiang Mai Universities. Dr. Sawangjit mentors students in clinical pharmacology, integrating research and practice 🧪✨. As a Clinical Research Associate (2009–2020), she contributed to impactful public health policies 🌍💡. She also led health promotion projects and served as Assistant Dean for Student Affairs (2013–2015) 🎓🤝. Currently, she heads the IRB/EC, ensuring ethical compliance in research standards ✅📋.

Research Expertise

Assist. Prof. Dr. Ratree Sawangjit is an expert in clinical trials, specializing in the design, implementation, and analysis of studies with a focus on herbal and alternative medicines 🌿🧪. She excels in evidence-based synthesis, conducting systematic reviews, meta-analyses, and network meta-analyses 📚📊. Her expertise extends to clinical pharmacology, particularly in pain and inflammation management 💊🔥. Additionally, she is proficient in health economic evaluation, including cost-effectiveness analysis and healthcare resource utilization analysis 💰🏥. Dr. Sawangjit’s work combines cutting-edge research with practical applications, advancing both patient care and healthcare efficiency. 🌟

Awards and Honors

Assist. Prof. Dr. Ratree Sawangjit is an accomplished academic and researcher. She earned a Bachelor of Pharmacy with second-class honors from Chiang Mai University in 2004 🎓💊. Supported by the Thailand Research Fund, she completed her Master’s (2004–2006) and Ph.D. (2008–2012) programs 🧠📚. As a visiting research assistance scholar, she collaborated with Monash University’s School of Pharmacy in Malaysia (2015–2016) 🌏🔬. She was named Outstanding Researcher of the Faculty of Pharmacy at Mahasarakham University in 2019 and Outstanding Researcher of Mahasarakham University in 2021 🏆✨. Her journey reflects dedication to advancing pharmaceutical education and research. 🌟

Research Focus

Assist. Prof. Dr. Ratree Sawangjit’s research focuses on evidence-based healthcare, particularly through systematic reviews and meta-analyses. Her studies span diverse areas, including burn wound healing 🌱🔥, pharmacological treatments for dementia-related agitation 🧠💊, peripheral neuropathy 🌐🦶, and nonalcoholic fatty liver disease 🩺🫀. She has also investigated the cost-effectiveness of genetic testing in preventing drug-induced reactions 🧬💉 and assessed cannabis and cannabinoids for pain management 🌿🤕. Other key areas include treatments for eczema 🧴🛁 and musculoskeletal pain 🦴🩹. Dr. Sawangjit’s work significantly contributes to optimizing therapeutic interventions and advancing global health outcomes. 🌍📚

Publication Top Notes

The efficacy of aloe vera used for burn wound healing: a systematic review

Cost-effectiveness analysis of HLA-B* 5801 testing in preventing allopurinol-induced SJS/TEN in Thai population

Effectiveness of pharmacy‐based needle/syringe exchange programme for people who inject drugs: a systematic review and meta‐analysis

Pharmacological treatments for alleviating agitation in dementia: a systematic review and network meta‐analysis

Efficacy and safety of mecobalamin on peripheral neuropathy: a systematic review and meta-analysis of randomized controlled trials

Comparative efficacy of interventions on nonalcoholic fatty liver disease (NAFLD): A PRISMA-compliant systematic review and network meta-analysis

The effects of cannabis, cannabinoids, and their administration routes on pain control efficacy and safety: A systematic review and network meta-analysis

 

 

 

Dr. Michel Fares|Drug analysis|Best Researcher Award

Dr. Michel Fares|Drug analysis|Best Researcher Award

Dr. Michel Fares at Nahda University,Egypt

PROFILE  

scopus

Orcid

Google scholar

 

 

Early Academic Pursuits 📚

Michel Yousry Fares embarked on his academic journey with a strong foundation in pharmaceutical sciences, receiving his Bachelor of Pharmacy degree from Nahda University in Beni Suef, Egypt, in 2013. Graduating with honors and a high GPA of 3.89, he demonstrated an early commitment to excellence in his field. His passion for analytical chemistry led him to pursue a Master’s degree in Pharmaceutical Analytical Chemistry at Beni Suef University, where he further honed his skills and knowledge. In 2022, Michel earned his Ph.D. in Pharmaceutical Analytical Chemistry from Cairo University, solidifying his expertise in the analytical methods used to assess pharmaceutical compounds.

Professional Endeavors 🏫

Currently, Michel serves as a Lecturer in the Pharmaceutical Analytical Chemistry Department at Nahda University’s Faculty of Pharmacy, a position he has held since 2022. In this role, he teaches a variety of undergraduate courses, including Pharmaceutical Analytical Chemistry, Instrumental Analysis, and Quality Control of Pharmaceuticals. His responsibilities also extend to research activities in the field of analytical chemistry, where he contributes to advancing the understanding and application of various analytical techniques, such as chromatography and spectroscopy. Michel also plays a key role in mentoring and advising students, helping shape the future of aspiring pharmaceutical professionals.

Beyond his teaching responsibilities, Michel serves as the Vice President of Electronic Learning Support (ELS) at Nahda University, where he has been instrumental in developing and maintaining the university’s e-learning platform, Moodle. His efforts in training instructors and resolving technical issues have significantly enhanced the educational experience for both faculty and students at the university.

Contributions and Research Focus 🔬

Michel’s primary research interests lie in the field of pharmaceutical analytical chemistry, with a specific focus on drug analysis, bioanalysis, and the development of innovative analytical techniques. He has authored several research articles and reviews, including a prominent piece on miniaturized solid-phase extraction techniques for analyzing various pollutants. This work highlights his commitment to advancing analytical methods for environmental and pharmaceutical applications.

His research endeavors also extend to the study of pharmacokinetic parameters, quality assurance, and experimental design. By applying a range of analytical techniques, Michel contributes to improving the quality and safety of pharmaceutical products. His focus on practical applications of pharmaceutical analysis aims to bridge the gap between theoretical knowledge and real-world problem-solving in the pharmaceutical industry.

Accolades and Recognition 🏅

Michel’s contributions to both research and education have not gone unnoticed. He was honored with the “Best Research Publishing Record in the Teaching Assistant Category” in 2022 at Nahda University, a testament to his dedication to advancing scientific knowledge. In 2021, he received the “Best Scientific Research in the Field of Applied Pharmaceutical Sciences” award from ACDIMA (The Arab Company for Drug Industries and Medical Appliances), further cementing his reputation as a leading figure in his field.

Michel’s contributions extend beyond the classroom and laboratory, as he has been actively involved in organizing and participating in scientific conferences. Notably, he was a key participant in the 3rd International Conference of the Faculty of Pharmacy at Ain Shams University and the 2nd International Conference of Pharmaceutical & Therapeutical Science in 2023, where he presented on topics such as online education and creativity in analytical chemistry.

Impact and Influence 🌍

Through his work in both academia and research, Michel has had a profound impact on the field of pharmaceutical sciences. His innovative research has contributed to the development of more efficient and accurate analytical methods, particularly in drug analysis and bioanalysis. As a teacher, he has shaped the careers of many future pharmacists and analytical chemists, emphasizing the importance of precision and quality in pharmaceutical testing.

Michel’s influence extends beyond his direct teaching and research contributions. He has been a reviewer for several prestigious scientific journals, including TrAC Trends in Analytical Chemistry and Journal of Pharmaceutical and Biomedical Analysis, where his expertise helps shape the direction of future research in the field.

Legacy and Future Contributions 🌱

Michel’s legacy is one of dedication to the advancement of pharmaceutical sciences and the education of the next generation of professionals. His work in the development of analytical techniques has had a lasting impact on both the academic and pharmaceutical industries, and his commitment to improving the quality of education will continue to benefit students for years to come.

Looking forward, Michel plans to continue his research into novel analytical methods, with a focus on environmental applications and the use of cutting-edge technologies like electrochemistry and chromatography. His goal is to contribute to the development of sustainable practices within pharmaceutical analysis, ensuring that future generations of scientists have the tools they need to meet the evolving challenges of the global pharmaceutical industry.

In addition to his research, Michel is committed to furthering his role in educational leadership, particularly in the integration of digital technologies into the learning process. He envisions a future where e-learning systems are more widely adopted, creating a more accessible and flexible learning environment for students around the world.

Conclusion ✨

Michel Yousry Fares stands out as a dedicated educator, researcher, and leader in the field of pharmaceutical analytical chemistry. His career is characterized by his commitment to excellence in both teaching and research, his impact on the development of analytical methods, and his dedication to shaping the future of pharmaceutical sciences. Through his ongoing work, Michel will continue to leave a positive and lasting legacy in the field, inspiring future generations of scientists and educators.

🎓Publication 

Green analytical chemistry as an integral part of sustainable education development

  • Authors   : Justyna Płotka-Wasylka, Heba M Mohamed, Aleksandra Kurowska-Susdorf, Rajkumar Dewani, Michel Y Fares, Vasil Andruch
  • Journal    :Current Opinion in Green and Sustainable Chemistry
  • Year         :2021

Determination of the abused intravenously self-administered madness drops (Tropicamide) by liquid chromatography in rat plasma; an application to pharmacokinetic study and …

  • Authors   : Maha M Abdelrahman, Nada S Abdelwahab, Maha A Hegazy, Michel Y Fares, Ghada M EL-Sayed
  • Journal    : Microchemical Journal
  • Year         :2020

Determination of sofosbuvir with two co-administered drugs; paracetamol and DL-methionine by two chromatographic methods. Application to a pharmacokinetic study

  • Authors   :Michel Y Fares, Nada S Abdelwahab, Maha M Abdelrahman, Hamdy M Abdel-Rahman
  • Journal    : Bioanalysis
  • Year         :2019

Miniaturized solid phase extraction techniques for different kind of pollutants analysis: state of the art and future perspectives–PART 1

  • Authors   : Justyna Płotka-Wasylka, Natalia Jatkowska, Monika Paszkiewicz, Magda Caban, Michel Y Fares, Aysegul Dogan, Salvador Garrigues, Natalia Manousi, Natasa Kalogiouri, Paweł Mateusz Nowak, Victoria F Samanidou, Miguel de la Guardia
  • Journal    :TrAC Trends in Analytical Chemistry
  • Year         :2023

Quality by design approach for green HPLC method development for simultaneous analysis of two thalassemia drugs in biological fluid with pharmacokinetic study

  • Authors   : Michel Y Fares, Maha A Hegazy, Ghada M El-Sayed, Maha M Abdelrahman, Nada S Abdelwahab
  • Journal    :RSC advances
  • Year         :2022

Prof Dr. Ronit Sverdlov|Pharmacology|Best Researcher Award

Prof Dr. Ronit Sverdlov|Pharmacology|Best Researcher Award

Prof Dr. Ronit Sverdlov at Maastricht University,Netherlands

PROFILE  

ORCID

Scopus

 

Early Academic Pursuits 🎓

Dr. Ronit Shiri-Sverdlov’s academic journey began with a Master’s degree in Biochemistry and Cellular Biology from Tel-Aviv University in Israel, where she graduated magna cum laude. This period was instrumental in shaping her deep interest in cellular and molecular mechanisms, a theme that would remain central to her later work. Building on her foundational knowledge, she pursued a Ph.D. in Molecular Genetics at Tel-Aviv University’s Sheba Medical Center, under the supervision of Prof. E. Friedman. Her doctoral research, focused on identifying germline mutations in the BRCA1 and BRCA2 genes among high-risk Jewish and Arab populations, underscored her commitment to precision genetics and earned her a magna cum laude distinction upon graduation in 2002.

Professional Endeavors 💼

Dr. Shiri-Sverdlov joined Maastricht University’s Department of Molecular Genetics in 2001 as a postdoctoral researcher, working with Prof. M.H. Hofker. Her early postdoctoral work provided the groundwork for her lifelong focus on metabolic health, hepatic inflammation, and cholesterol metabolism. In 2004, she transitioned into a faculty position, first as an Assistant Professor and later, an Associate Professor by 2012. In 2016, she was appointed a Full Professor of Hepatic Inflammation and Metabolic Health, reflecting her leadership and expertise in the field. Dr. Shiri-Sverdlov currently leads a vibrant research team within the Faculty of Health, Medicine, and Life Sciences at Maastricht University, where she oversees projects focusing on liver disease, metabolic health, and inflammation under the NUTRIM School of Nutrition and Translational Research in Metabolism.

Contributions and Research Focus 🔬

Dr. Shiri-Sverdlov’s research centers on understanding and combating liver-related diseases, particularly non-alcoholic steatohepatitis (NASH), through molecular insights into cholesterol trafficking and hepatic inflammation. Her investigations have brought critical attention to lysosomal dysfunction as a biomarker for early NASH detection. This research has garnered substantial support, including a €1 million TKI grant in 2017 and several large fellowships from the Dutch Digestive Foundation and NWO ZonMw. Her work emphasizes the role of cholesterol metabolism in Kupffer cells (liver macrophages) and its impact on inflammatory pathways—a field where her studies continue to yield promising therapeutic insights.

Accolades and Recognition 🏆

Over the years, Dr. Shiri-Sverdlov has earned numerous prestigious awards. Her early career was marked by the VENI, VIDI, and ASPASIA fellowships from NWO ZonMw, which collectively supported her pioneering work in cholesterol metabolism and liver inflammation. She received the Marie Sklodowska-Curie Seal of Excellence in 2018, reflecting her proposal’s high evaluation score. She was also awarded the Education Prize by Maastricht University in 2018 for her leadership in developing the Biomedical Sciences curriculum. Additionally, she has been nominated for multiple awards, reflecting her influence in both research and teaching.

Impact and Influence 🌐

Dr. Shiri-Sverdlov has made a significant impact in the field of hepatic health through her research and mentorship. Her work on hepatic lysosomal biomarkers has been pivotal in early disease detection for NASH, with implications for both clinical practice and drug development. As a member of key grant committees, including the Netherlands Organization for Scientific Research (NWO) and the Novo Nordisk Foundation, she actively shapes the research landscape. Her collaboration with researchers across Europe, including those at the University of Reading and Strasbourg University, has contributed to a robust network of shared knowledge and advances in metabolic health.

Legacy and Future Contributions 🌱

Looking to the future, Dr. Shiri-Sverdlov is committed to advancing the understanding of liver diseases through cutting-edge research. Her work not only contributes to therapeutic advancements in NASH and hepatic inflammation but also inspires the next generation of scientists. Through her teaching roles, she continues to influence and guide students in Biomedical Sciences and Nutrition, instilling in them a commitment to rigorous research. Her legacy is further enriched by her leadership in scientific societies, where she champions innovative approaches to metabolic and hepatic health research.

🎓Publication 

Plasma cathepsin D as an early indicator of alcohol-related liver disease

  • Authors   :Li, M., Houben, T., Bitorina, A.V., Thiele, M., Shiri-Sverdlov, R.
    JHEP Reports,
  • Year         :2024

The Modulatory Effects of Fatty Acids on Cancer Progression

  • Authors   :Westheim, A.J.F., Stoffels, L.M., Dubois, L.J., Shiri-Sverdlov, R., Theys, J.
  • Journal    : Biomedicines
  • Year         :2023

All Roads Lead to Cathepsins: The Role of Cathepsins in Non-Alcoholic Steatohepatitis-Induced Hepatocellular Carcinoma

  • Authors   :van Mourik, H., Li, M., Baumgartner, S., Theys, J., Shiri-Sverdlov, R.
  • Journal    :Biomedicines
  • Year         :2022

Fatty Acids as a Tool to Boost Cancer Immunotherapy Efficacy

  • Authors   : Westheim, A.J.F., Stoffels, L.M., Dubois, L.J., Shiri-Sverdlov, R., Theys, J.
  • Journal    : Frontiers in Nutrition
  • Year         :2022

Serum CathepsinD in pregnancy: Relation with metabolic and inflammatory markers and effects of fish oils and probiotics

  • Authors   : Mokkala, K., Gustafsson, J., Vahlberg, T., Plat, J., Laitinen, K.
  • Journal    :Nutrition, Metabolism and Cardiovascular Diseases
  • Year         :2022

Dr. Sukhendu Dey |Pharmacology |Best Researcher Award

Dr. Sukhendu Dey|Pharmacology|Best Researcher Award

Dr. Sukhendu Dey at The University of Burdwan,India

PROFILE  

Google scholar

Early Academic Pursuits 🎓

Dr. Sukhendu Dey was born on April 2, 1992, in West Bengal, India. He embarked on his academic journey with a deep interest in environmental sciences, obtaining a Ph.D. in Environmental Science. His focus areas during his doctoral studies included aquatic toxicology, fish hematology, and the use of biomarkers in environmental risk assessments.

Prior to his Ph.D., Dr. Dey completed his M.Sc. in Environmental Science, where he graduated with first-class honors. His consistent academic excellence also extended to a Post Graduate Diploma in Disaster Management, equipping him with the skills to address complex environmental challenges. Additionally, he earned a B.Ed. in Life Sciences, emphasizing his interest in education and knowledge dissemination.

Professional Endeavors 🔬

Currently serving as a Technical Assistant Gr.-II at The University of Burdwan, West Bengal, Dr. Dey plays a pivotal role in facilitating research and managing technical aspects of the university’s environmental science department. His 8-year research career has been supplemented by teaching experiences, where he imparted his knowledge in environmental toxicology and ecological sciences.

Dr. Dey’s professional focus lies in various interconnected areas of biochemistry, aquatic toxicology, risk assessment, and environmental toxicology. His research primarily revolves around understanding the biochemical impacts of pollutants on aquatic ecosystems, contributing to the development of new strategies for environmental preservation and sustainability.

Contributions and Research Focus 📚

Dr. Dey’s research contributions are both extensive and impactful. He has published over 30 research articles, 31 book chapters, and edited 5 books. His work spans across topics like biomarkers in aquatic systems, toxicity analysis, and the ecological impacts of pollutants.

Some of his significant research contributions are in the field of:

  • Fish Hematology: Understanding the blood parameters in fish as indicators of environmental stress.
  • Biomarkers: Developing methods to assess the health of aquatic environments through biochemical markers.
  • Aquatic Toxicology: Investigating the effects of chemical pollutants on aquatic organisms and ecosystems.

His scholarly publications are available on Google Scholar, where his research has been well-cited by peers across various domains, signifying the importance of his work in the scientific community.

Accolades and Recognition 🏅

Dr. Dey’s hard work and dedication have been recognized on numerous occasions. He was awarded the Environmental Research Excellence Award 2023 at the 9th International Conference on Environment and Ecology, a prestigious honor celebrating his contributions to environmental research. This accolade is a testament to his relentless pursuit of understanding and mitigating environmental issues.

Additionally, Dr. Dey has been an integral part of several conferences and seminars. He has organized and contributed to international and national-level seminars, workshops, and training programs on topics ranging from environmental crises to cutting-edge research techniques.

Impact and Influence 🌱

Dr. Dey’s influence extends beyond his research publications. He has actively participated in initiatives aimed at environmental conservation and sustainability. As a technical assistant at The University of Burdwan, he has mentored young researchers and students, fostering a new generation of environmental scientists.

He has played a significant role in organizing key events, such as the International Conference on Mother Earth: Save It to Achieve a Sustainable Future for All and the DST-PURSE Sponsored International Conference on Frontiers in Biological Environment and Medical Sciences. These efforts have brought together scientists, policymakers, and environmental advocates to discuss sustainable solutions for global environmental challenges.

In addition to his contributions at academic institutions, Dr. Dey is involved with the NGO Friends of the Earth (FOE), where he holds a lifetime membership. His work with the NGO reflects his commitment to using his scientific expertise for community-based environmental initiatives.

Legacy and Future Contributions 🚀

As Dr. Sukhendu Dey continues to explore the frontiers of environmental science, his legacy is one of passion, dedication, and impact. His research in aquatic toxicology and environmental toxicology has paved the way for better understanding the environmental risks posed by pollutants.

Dr. Dey’s future contributions are expected to expand further into the realm of environmental sustainability and risk mitigation, focusing on creating safer ecosystems and reducing the impacts of industrial and environmental pollutants.

Moreover, his involvement in interdisciplinary workshops and seminars indicates his desire to bridge the gap between research and practical applications, ensuring that his work has both scientific and societal relevance.

Conclusion 🌿

Dr. Sukhendu Dey’s career reflects an unwavering dedication to environmental science and its application in safeguarding ecosystems. From his early academic achievements to his ongoing professional endeavors, he has consistently contributed to the field of environmental toxicology. His awards, publications, and role in academic institutions mark him as a thought leader in his field, whose research has both national and international implications.

As a rising figure in environmental science, Dr. Dey’s legacy will continue to inspire future generations, promoting sustainability and environmental stewardship for years to come.

🎓Publication 

Integrative assessment of biomarker responses in teleostean fishes exposed to glyphosate-based herbicide (Excel Mera 71)

  • Authors   : Sukhendu Dey, Palas Samanta, Sandipan Pal, Aloke Kumar Mukherjee, Debraj Kole, Apurba Ratan Ghosh
  • Journal    :Emerging Contaminants
  • Year         :2016

Valorization of wastewater: A paradigm shift towards circular bioeconomy and sustainability

  • Authors   : Debajyoti Kundu, Deblina Dutta, Palas Samanta, Sukhendu Dey, Knawang Chhunji Sherpa, Sunil Kumar, Brajesh Kumar Dube
  • Journal    :Science of the Total Environment
  • Year         :2022

Dose specific responses of Anabas testudineus (Bloch) to anthracene (PAH): Haematological and biochemical manifestation

  • Authors   : Sukhendu Dey, Palas Samanta, Niladri Sekhar Mondal, Debraj Kole, Arghya Mandal, Atanu Patra, Apurba Ratan Ghosh
  • Journal    :Emerging Contaminants
  • Year         :2019

Time-Dependent Naphthalene Toxicity in Anabas testudineus (Bloch): A Multiple Endpoint Biomarker Approach

  • Authors   : Sukhendu Dey, Puspita Ballav, Palas Samanta, Arghya Mandal, Atanu Patra, Subhas Das, Arnab Kumar Mondal, Apurba Ratan Ghosh
  • Journal    :ACS omega
  • Year         :2020